MK-2225

Generic Name: MK-2225

Brand Names: -

Drug Type: Biotech

Chemical Formula: -

CAS Number: -

Unique Ingredient Identifier: -

Associated Conditions: -

Associated Therapies: -

Clinical Trials

A Study of MK-2225 in Healthy Participants (MK-2225-003)

Phase 1

Active, not recruiting

Conditions: Systemic Sclerosis

Interventions: Other: Placebo
Drug: MK-2225

First Posted Date: 2024-10-16

Last Posted Date: 2024-10-16

Lead Sponsor: Merck Sharp & Dohme LLC

Target Recruit Count: 24

Registration Number: NCT06643390

Locations: 🇺🇸
Bio-Kinetic Clinical Applications, LLC dba QPS-MO (Site 0004), Springfield, Missouri, United States
🇺🇸
Clinical Pharmacology of Miami (Site 0002), Miami, Florida, United States

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy